Kestrel Investment Management’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
Other funds holding PBH
AI
BIP
Kestrel Investment Management's PBH Position: Q2 2026 in Review
Kestrel Investment Management reduced its Prestige Consumer Healthcare (PBH) stake by 0.14% in Q2 2026, selling an estimated $5.14K and leaving 69,950 shares worth $3.31M. The position accounts for 1.8% of the portfolio, ranked #27.
Kestrel Investment Management first reported a position in PBH in Q3 2018 and has held it in 24 quarters since. The position peaked at $8.3M in Q2 2021. 320 funds tracked by Wall St. Rank hold PBH as of Q2 2026.
- Kestrel Investment Management held 69,950 shares of Prestige Consumer Healthcare worth $3.31M as of Q2 2026.
- Kestrel Investment Management sold 100 Prestige Consumer Healthcare shares in Q2 2026, an estimated $5.14K.
- Prestige Consumer Healthcare made up 1.8% of Kestrel Investment Management's portfolio in Q2 2026, its #27 holding.
- Kestrel Investment Management first reported a position in Prestige Consumer Healthcare in Q3 2018 and has held it in 24 quarters since.
- Kestrel Investment Management's Prestige Consumer Healthcare position peaked at $8.3M in Q2 2021.
- 320 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.
Based on Kestrel Investment Management's 13F filing for Q2 2026, filed 4 Aug 2026.